Evidence map›Paper›PMID 22780320›Full record

ArticleBioTechniques2012

Effective flow cytometric phenotyping of cells using minimal amounts of antibody.

Deepak Sharma, Mark R Eichelberg, Jill D Haag, Amanda L Meilahn, Matthew J Muelbl, Kathy Schell, Bart M G Smits, Michael N Gould

Abstract read
In one paragraph

Article in BioTechniques, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Malabaricone C, a constituent of spiceJournal of biosciences · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Deepak SharmaDepartment of Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
Mark R Eichelberg
Jill D Haag
Amanda L Meilahn
Matthew J Muelbl
Kathy Schell
Bart M G Smits
Michael N Gould

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
WKY RAT GENETIC MODEL FOR BREAST CANCER SUSCEPTIBILITYR01CA077494 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 1998 to 2012
$3.7M
Genetics of Breast Cancer Risk at Windows of ExposureU01ES019466 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 2010 to 2014
$2.2M
Characterizing a Breast Cancer Modifier Locus That Associates with Human RiskR01CA123272 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 2006 to 2010
$2.1M
NCI NIH HHS CA077494NCI NIH HHS CA123272NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA077494NCI NIH HHS R01 CA123272NIEHS NIH HHS ES019466NIEHS NIH HHS U01 ES019466
6 · The paper itself

Abstract

Here we introduce a modified antibody staining method that uses up to 80% less antibody for flow cytometry. We demonstrate this method for the detection of antigens expressed at high, moderate, or low levels in mouse and rat lymphocytes as well as mouse mammary epithelial cells. We obtained reproducibly accurate results for the detection of up to seven parameters for activation induced-proliferation, cell cycle analysis, and phenotyping of cell-surface and intracellular antigens.

Indexed as

AnimalsAntigens, CDCells, CulturedEpithelial CellsFemaleFlow CytometryLymphocytesMammary Glands, AnimalMiceRatsSample SizeStaining and LabelingAntigens, CD

Identifiers

PMID22780320
PMCPMC3523330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.